[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-001", "question": "A 16-year-old female presents with episodes of muscle weakness and palpitations. Physical exam reveals low-set ears, micrognathia, and clinodactyly. ECG demonstrates frequent PVCs, a QTc of 490 ms, and prominent U waves. Genetic testing confirms a loss-of-function mutation in KCNJ2. She continues to have frequent non-sustained ventricular tachycardia despite beta-blocker therapy. What is the most appropriate pharmacologic management for her arrhythmia?", "options": ["Option A: Nadolol", "Option B: Amiodarone", "Option C: Flecainide", "Option D: Mexiletine", "Option E: Verapamil"], "answer": "C", "answer_index": 2, "explanation": "This patient has Andersen-Tawil Syndrome (LQT7), characterized by the triad of periodic paralysis, dysmorphic features, and QT/U wave abnormalities. Unlike other Long QT Syndromes where sodium channel blockers are often contraindicated, Flecainide is uniquely effective in suppressing the ventricular arrhythmias associated with KCNJ2 mutations.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: Andersen-Tawil syndrome (ATS, LQT7) with KCNJ2 mutation, frequent non-sustained VT despite beta-blocker. The unique pathophysiology of ATS involves loss-of-function in the inward rectifier potassium channel, leading to prolonged terminal repolarization (prominent U waves). While flecainide is a sodium channel blocker, its use in ATS is not standard first-line therapy and is not uniquely effective per major guidelines. The established, guideline-supported pharmacologic management for ventricular arrhythmias in ATS, after beta-blocker failure, is typically a class 1B antiarrhythmic like mexiletine. This makes option D (Mexiletine) the most appropriate and defensible best answer based on current consensus, not option C. The item is medically inaccurate in its rationale. Minimal fix: Change the key to D (Mexiletine) and update the rationale to reflect guideline recommendations for ATS.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: Andersen-Tawil syndrome (ATS, LQT7) with KCNJ2 mutation, frequent non-sustained VT despite beta-blocker. The unique pathophysiology of ATS involves loss-of-function in the inward rectifier potassium channel, leading to prolonged terminal repolarization (prominent U waves). While flecainide is a sodium channel blocker, its use in ATS is not standard first-line therapy and is not uniquely effective per major guidelines. The established, guideline-supported pharmacologic management for ventricular arrhythmias in ATS, after beta-blocker failure, is typically a class 1B antiarrhythmic like mexiletine. This makes option D (Mexiletine) the most appropriate and defensible best answer based on current consensus, not option C. The item is medically inaccurate in its rationale. Minimal fix: Change the key to D (Mexiletine) and update the rationale to reflect guideline recommendations for ATS.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-002", "question": "A 55-year-old man presents with bone pain and exophthalmos. CT imaging reveals perinephric infiltration with a 'hairy kidney' appearance and osteosclerotic lesions in the distal femur. Biopsy of the retroperitoneal tissue shows infiltration by foamy histiocytes that are CD68+ and CD1a-. Molecular testing reveals a BRAF V600E mutation. Which therapeutic agent is most indicated?", "options": ["Option A: Rituximab", "Option B: High-dose Prednisone", "Option C: Vemurafenib", "Option D: Methotrexate", "Option E: Infliximab"], "answer": "C", "answer_index": 2, "explanation": "The clinical presentation (hairy kidney, osteosclerosis, exophthalmos) and pathology (CD68+, CD1a- foamy histiocytes) are diagnostic of Erdheim-Chester Disease (ECD), a non-Langerhans cell histiocytosis. Over 50% of cases carry the BRAF V600E mutation. Targeted therapy with a BRAF inhibitor (Vemurafenib) is the treatment of choice for BRAF-positive ECD, superior to empiric immunosuppression.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: bone pain, exophthalmos, 'hairy kidney' (perinephric infiltration), osteosclerotic lesions, CD68+/CD1a- foamy histiocytes, and BRAF V600E mutation are pathognomonic for Erdheim-Chester Disease (ECD). The presence of the BRAF mutation directly indicates targeted therapy. Main logical issue: None; the item is well-specified and leads to a single best answer. Main medical accuracy issue: None; the association of BRAF V600E in ECD and the use of vemurafenib is standard, guideline-supported care. Minimal fix: None required for validity; for enhanced clarity, the stem could explicitly state 'Erdheim-Chester Disease' after the biopsy description, but it is already strongly implied.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: bone pain, exophthalmos, 'hairy kidney' (perinephric infiltration), osteosclerotic lesions, CD68+/CD1a- foamy histiocytes, and BRAF V600E mutation are pathognomonic for Erdheim-Chester Disease (ECD). The presence of the BRAF mutation directly indicates targeted therapy. Main logical issue: None; the item is well-specified and leads to a single best answer. Main medical accuracy issue: None; the association of BRAF V600E in ECD and the use of vemurafenib is standard, guideline-supported care. Minimal fix: None required for validity; for enhanced clarity, the stem could explicitly state 'Erdheim-Chester Disease' after the biopsy description, but it is already strongly implied.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-003", "question": "A 32-year-old G1P0 woman at 35 weeks gestation presents with nausea, vomiting, and jaundice. Labs show AST 300 U/L, ALT 350 U/L, Platelets 80,000/mm3, Glucose 45 mg/dL, and INR 2.5. A diagnosis of Acute Fatty Liver of Pregnancy (AFLP) is made, and the infant is delivered urgently. To prevent sudden death in the neonate, which specific screening test should be prioritized?", "options": ["Option A: Serum ammonia and lactate", "Option B: Plasma acylcarnitine profile", "Option C: Galactose-1-phosphate uridyltransferase", "Option D: Very long-chain fatty acids (VLCFA)", "Option E: Hemoglobin electrophoresis"], "answer": "B", "answer_index": 1, "explanation": "Maternal AFLP is strongly associated with fetal Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency. Fetal fatty acid oxidation defects cause accumulation of metabolites that cross the placenta and overwhelm the maternal liver. The neonate is at high risk for hypoketotic hypoglycemia and sudden death; an acylcarnitine profile is diagnostic.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: Maternal AFLP at 35 weeks, delivered neonate, and the explicit link to preventing sudden death. The item correctly identifies the established association between maternal AFLP and fetal LCHAD deficiency, a fatty acid oxidation disorder. The acylcarnitine profile (Option B) is the specific, first-line screening test for this condition in the neonate. Alternatives are incorrect: A (ammonia/lactate) is non-specific; C (GALT) screens for galactosemia; D (VLCFA) screens for peroxisomal disorders; E (Hb electrophoresis) screens for hemoglobinopathies. No logical contradictions or missing details. Medical accuracy is sound. Minimal fix: None required; the item is clear and accurate as written.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 867)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-004", "question": "A 24-year-old male with HIV and known G6PD deficiency develops cyanosis and dyspnea after receiving dapsone. SpO2 is 85% and arterial blood is chocolate-colored. Methemoglobin level is 25%. He is inadvertently treated with methylene blue, after which his condition deteriorates with evidence of acute hemolysis and worsening hypoxia. What is the most appropriate next step in management?", "options": ["Option A: Repeat Methylene Blue dose", "Option B: High-dose Ascorbic Acid (Vitamin C)", "Option C: Exchange transfusion", "Option D: Hyperbaric oxygen therapy", "Option E: Hydroxocobalamin"], "answer": "C", "answer_index": 2, "explanation": "Methylene blue requires NADPH (generated via the G6PD pathway) to reduce methemoglobin. In G6PD deficiency, it is ineffective and can induce severe hemolysis (as seen here). Ascorbic acid is too slow for acute severe toxicity. Exchange transfusion is the definitive rescue therapy to rapidly remove the methemoglobin and the offending agent.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: G6PD-deficient patient with dapsone-induced methemoglobinemia (25%) deteriorates after methylene blue, with acute hemolysis and worsening hypoxia. This scenario uniquely indicates methylene blue is contraindicated and ineffective, creating a life-threatening emergency. The logical flow is sound: methylene blue fails and causes harm, so the next step must be a rescue therapy that does not rely on the G6PD pathway. Exchange transfusion (C) is the established definitive intervention to rapidly remove methemoglobin and damaged red cells. Alternatives are inferior: repeat methylene blue (A) would worsen hemolysis; ascorbic acid (B) is too slow; hyperbaric oxygen (D) is adjunctive, not definitive; hydroxocobalamin (E) is for cyanide, not methemoglobinemia. Medical accuracy is high, aligning with standard hematology/tox guidelines. Minimal fix: none required; item is clear and accurate.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 1064)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-005", "question": "A 3-month-old male presents with generalized erythroderma, lymphadenopathy, hepatosplenomegaly, and chronic diarrhea. CBC reveals eosinophilia and lymphocytosis. Immunophenotyping shows an absence of B cells, but elevated numbers of oligoclonal, activated T cells. Which genetic defect is most consistent with this presentation?", "options": ["Option A: BTK mutation", "Option B: Hypomorphic RAG1/RAG2 mutation", "Option C: CD40 Ligand mutation", "Option D: STAT3 mutation", "Option E: WAS gene mutation"], "answer": "B", "answer_index": 1, "explanation": "This is Omenn Syndrome, a form of 'leaky' Severe Combined Immunodeficiency (SCID). It is caused by hypomorphic mutations in RAG1 or RAG2 that allow for partial V(D)J recombination. This results in the absence of B cells but the development of a restricted, autoreactive T-cell repertoire that infiltrates tissues (erythroderma, hepatosplenomegaly) and causes high IgE/eosinophilia.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: infant with erythroderma, lymphadenopathy, hepatosplenomegaly, chronic diarrhea, eosinophilia, lymphocytosis, absent B cells, and oligoclonal activated T cells. This constellation is classic for Omenn syndrome, a hypomorphic SCID. The keyed answer (B, hypomorphic RAG1/RAG2 mutation) is the definitive genetic cause. Alternatives are incorrect: BTK (A) causes X-linked agammaglobulinemia (no T cells); CD40L (C) causes Hyper-IgM syndrome (different phenotype); STAT3 (D) causes Hyper-IgE syndrome (no B-cell absence); WAS (E) causes Wiskott-Aldrich syndrome (thrombocytopenia, eczema). No logical contradictions or missing details. Medical accuracy is sound. Minimal fix: None required; item is clear and accurate.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: infant with erythroderma, lymphadenopathy, hepatosplenomegaly, chronic diarrhea, eosinophilia, lymphocytosis, absent B cells, and oligoclonal activated T cells. This constellation is classic for Omenn syndrome, a hypomorphic SCID. The keyed answer (B, hypomorphic RAG1/RAG2 mutation) is the definitive genetic cause. Alternatives are incorrect: BTK (A) causes X-linked agammaglobulinemia (no T cells); CD40L (C) causes Hyper-IgM syndrome (different phenotype); STAT3 (D) causes Hyper-IgE syndrome (no B-cell absence); WAS (E) causes Wiskott-Aldrich syndrome (thrombocytopenia, eczema). No logical contradictions or missing details. Medical accuracy is sound. Minimal fix: None required; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-006", "question": "A 4-month-old infant presents with failure to thrive and diaphoresis during feeding. ECG reveals deep Q waves in leads I, aVL, and V5-V6. Echocardiography demonstrates a dilated left ventricle. During color Doppler interrogation of the coronary arteries, which flow pattern confirms the diagnosis of Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA)?", "options": ["Option A: Diastolic flow from the aorta into the left coronary artery", "Option B: Systolic flow from the pulmonary artery into the left coronary artery", "Option C: Retrograde flow from the left coronary artery into the pulmonary artery", "Option D: Continuous flow from the aorta to the pulmonary artery", "Option E: Turbulent high-velocity flow at the left coronary ostium"], "answer": "C", "answer_index": 2, "explanation": "In the infant/adult type of ALCAPA, pulmonary vascular resistance drops, causing flow reversal. Blood flows from the aorta to the Right Coronary Artery, through collaterals to the Left Coronary Artery, and then retrograde into the low-pressure Pulmonary Artery (coronary steal). The hallmark is retrograde flow into the PA.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: 4-month-old with failure to thrive, diaphoresis, ECG deep Q waves (I, aVL, V5-V6) indicating anterolateral ischemia, and dilated left ventricle are classic for ALCAPA. The question asks for the confirmatory Doppler flow pattern. The keyed answer (C) correctly identifies retrograde flow from the left coronary artery into the pulmonary artery, which is the pathognomonic 'coronary steal' phenomenon in ALCAPA after pulmonary vascular resistance drops. All other options describe incorrect or non-specific flow patterns. No logical contradictions or missing details. Medical accuracy is sound. Minimal fix: None required; the item is clear and accurate.\",\n    \"logical_false_reason\": \"T\",\n    \"logical_validity\": true,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 824)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-007", "question": "A 60-year-old male presents with nephrotic syndrome. Labs show low serum C3 and normal C4. Kidney biopsy reveals C3-dominant staining on immunofluorescence and a membranoproliferative pattern on light microscopy. Serum protein electrophoresis is negative, but serum free light chain assay shows a kappa:lambda ratio of 5.0. What is the most appropriate treatment to preserve renal function?", "options": ["Option A: Eculizumab", "Option B: Mycophenolate Mofetil", "Option C: Clone-directed chemotherapy (e.g., Bortezomib-based)", "Option D: High-dose steroids alone", "Option E: Plasma exchange"], "answer": "C", "answer_index": 2, "explanation": "This patient has C3 Glomerulopathy (C3G) secondary to a Monoclonal Gammopathy of Renal Significance (MGRS). The monoclonal protein acts as an autoantibody (e.g., C3 nephritic factor) driving complement activation. The standard of care is to treat the underlying clone (plasma cell directed therapy) rather than non-specific immunosuppression or complement inhibition alone.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: nephrotic syndrome, low C3/normal C4, C3-dominant IF, MPGN pattern, and an abnormal serum free light chain ratio (5.0). The findings are classic for C3 glomerulopathy (C3G). The presence of a monoclonal gammopathy (MGRS) suggests a possible driving autoantibody. Main logical issue: The key (C, clone-directed chemotherapy) is not the single best answer. The vignette does not confirm a plasma cell clone; the abnormal light chain ratio alone, without confirmation of a monoclonal protein (SPEP negative), is insufficient to diagnose MGRS and justify chemotherapy. Eculizumab (A) is a first-line, evidence-based treatment for C3G. This creates a miskey (K) and a scenario where multiple answers are defensible (M). Main medical accuracy issue: Overstating the diagnostic certainty for MGRS. Minimal fix: Specify a positive serum immunofixation or bone marrow biopsy confirming a clonal disorder to make clone-directed therapy the clear best answer.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K. Verdict on keyed answer: Miskeyed. Key stem clues: nephrotic syndrome, low C3/normal C4, C3-dominant IF, MPGN pattern, and an abnormal serum free light chain ratio (5.0). The findings are classic for C3 glomerulopathy (C3G). The presence of a monoclonal gammopathy (MGRS) suggests a possible driving autoantibody. Main logical issue: The key (C, clone-directed chemotherapy) is not the single best answer. The vignette does not confirm a plasma cell clone; the abnormal light chain ratio alone, without confirmation of a monoclonal protein (SPEP negative), is insufficient to diagnose MGRS and justify chemotherapy. Eculizumab (A) is a first-line, evidence-based treatment for C3G. This creates a miskey (K) and a scenario where multiple answers are defensible (M). Main medical accuracy issue: Overstating the diagnostic certainty for MGRS. Minimal fix: Specify a positive serum immunofixation or bone marrow biopsy confirming a clonal disorder to make clone-directed therapy the clear best answer.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-008", "question": "A patient with severe ARDS is ventilated in Assist-Control Volume Control mode. He is deeply sedated but not paralyzed. Ventilator graphics display a time-triggered mandatory breath, followed immediately by a drop in esophageal pressure (diaphragmatic contraction) occurring during the inspiratory phase, which triggers a second breath during exhalation (breath stacking). This phenomenon is best described as:", "options": ["Option A: Double triggering due to flow starvation", "Option B: Reverse triggering", "Option C: Ineffective triggering", "Option D: Premature cycling", "Option E: Auto-triggering"], "answer": "B", "answer_index": 1, "explanation": "Reverse triggering is a form of patient-ventilator dyssynchrony where the passive insufflation from the ventilator mechanically stretches the diaphragm, reflexively inducing a patient respiratory effort (entrainment). If this induced effort is strong enough, it can trigger a second breath (breath stacking). It is distinct from double triggering caused by high patient drive.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: deeply sedated (not paralyzed), time-triggered mandatory breath, drop in esophageal pressure (diaphragmatic contraction) during the inspiratory phase, triggers a second breath during exhalation (breath stacking). This sequence precisely matches the definition of reverse triggering, where a ventilator breath induces a diaphragmatic contraction. The item is logically valid and medically accurate. The keyed answer (B) is the single best fit. Alternatives are incorrect: double triggering (A) is from high drive, not a passive stretch; ineffective triggering (C) is a missed effort; premature cycling (D) is early termination; auto-triggering (E) is from artifact. No contradictions or missing details. Minimal fix: None required; the item is clear and correct.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: deeply sedated (not paralyzed), time-triggered mandatory breath, drop in esophageal pressure (diaphragmatic contraction) during the inspiratory phase, triggers a second breath during exhalation (breath stacking). This sequence precisely matches the definition of reverse triggering, where a ventilator breath induces a diaphragmatic contraction. The item is logically valid and medically accurate. The keyed answer (B) is the single best fit. Alternatives are incorrect: double triggering (A) is from high drive, not a passive stretch; ineffective triggering (C) is a missed effort; premature cycling (D) is early termination; auto-triggering (E) is from artifact. No contradictions or missing details. Minimal fix: None required; the item is clear and correct.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-009", "question": "A 28-year-old G2P2 woman presents 3 months postpartum with extensive ecchymoses and bleeding from a minor cut. Coagulation studies show aPTT 78s and PT 12s. A mixing study fails to correct the aPTT. Factor VIII activity is <1%. Which agent is the most appropriate first-line therapy for acute bleeding control?", "options": ["Option A: Desmopressin (DDAVP)", "Option B: Cryoprecipitate", "Option C: Recombinant Human Factor VIII", "Option D: Recombinant Porcine Factor VIII", "Option E: High-dose Prednisone"], "answer": "D", "answer_index": 3, "explanation": "This is acquired hemophilia A (postpartum), caused by an inhibitor (autoantibody) to Factor VIII. Human Factor VIII (and Cryoprecipitate) will be neutralized by the inhibitor and is ineffective. First-line hemostatic agents are bypassing agents (rFVIIa or FEIBA) or Recombinant Porcine Factor VIII (which has low cross-reactivity with human anti-FVIII antibodies). Prednisone treats the clone but does not stop acute bleeding.", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: postpartum woman with isolated prolonged aPTT, factor VIII <1%, and a mixing study that fails to correct, confirming an acquired factor VIII inhibitor (acquired hemophilia A). For acute bleeding control, first-line therapy is a bypassing agent (recombinant factor VIIa or FEIBA) or recombinant porcine factor VIII. However, the keyed answer (D, recombinant porcine factor VIII) is not the sole, definitive first-line choice; bypassing agents are equally valid first-line options per major guidelines, making option C (recombinant human factor VIII) the only clearly incorrect choice for hemostasis. The item presents multiple defensible first-line therapies (M secondary). Medical accuracy is sound. Minimal fix: Change the key to the most guideline-supported first-line class (e.g., 'Bypassing agent (rFVIIa or FEIBA)') or rephrase the question to ask for an agent that is specifically ineffective, making C the correct key.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: postpartum woman with isolated prolonged aPTT, factor VIII <1%, and a mixing study that fails to correct, confirming an acquired factor VIII inhibitor (acquired hemophilia A). For acute bleeding control, first-line therapy is a bypassing agent (recombinant factor VIIa or FEIBA) or recombinant porcine factor VIII. However, the keyed answer (D, recombinant porcine factor VIII) is not the sole, definitive first-line choice; bypassing agents are equally valid first-line options per major guidelines, making option C (recombinant human factor VIII) the only clearly incorrect choice for hemostasis. The item presents multiple defensible first-line therapies (M secondary). Medical accuracy is sound. Minimal fix: Change the key to the most guideline-supported first-line class (e.g., 'Bypassing agent (rFVIIa or FEIBA)') or rephrase the question to ask for an agent that is specifically ineffective, making C the correct key.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed126", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed126-010", "question": "A traveler returns from Malaysian Borneo with daily high-grade fevers and severe thrombocytopenia. Blood smear reveals high parasitemia with 'band form' trophozoites resembling Plasmodium malariae, but the clinical severity mimics Plasmodium falciparum. Which feature distinguishes the replication cycle of this pathogen from P. falciparum?", "options": ["Option A: 24-hour erythrocytic cycle", "Option B: 48-hour erythrocytic cycle", "Option C: 72-hour erythrocytic cycle", "Option D: Presence of a hypnozoite stage", "Option E: Preferential invasion of reticulocytes"], "answer": "A", "answer_index": 0, "explanation": "The pathogen is Plasmodium knowlesi, a zoonotic malaria. A key feature driving its potential for hyperparasitemia and severe disease is its unique 24-hour (quotidian) erythrocytic replication cycle. P. falciparum has a 48-hour cycle, and P. malariae has a 72-hour cycle. P. knowlesi does not have a hypnozoite stage (unlike P. vivax/ovale).", "generator_model": "gemini-3-pro-preview", "seed": 126, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: traveler from Malaysian Borneo, severe disease with high parasitemia, band forms resembling P. malariae, clinical severity like P. falciparum. The described pathogen is Plasmodium knowlesi. Its distinguishing replication feature is a 24-hour erythrocytic cycle (Option A), which is correct. However, the provided key is 'A', which matches the correct answer, so the item is not miskeyed. The logical failure is actually 'V' (Valid). The stem provides sufficient unique clues (geography, morphology, severity) to identify P. knowlesi, and its 24-hour cycle is a key, distinguishing fact. No contradictions or underspecification exist. Medical accuracy is sound. Minimal fix: None needed for validity; the item is logically and medically sound as written.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: traveler from Malaysian Borneo, severe disease with high parasitemia, band forms resembling P. malariae, clinical severity like P. falciparum. The described pathogen is Plasmodium knowlesi. Its distinguishing replication feature is a 24-hour erythrocytic cycle (Option A), which is correct. However, the provided key is 'A', which matches the correct answer, so the item is not miskeyed. The logical failure is actually 'V' (Valid). The stem provides sufficient unique clues (geography, morphology, severity) to identify P. knowlesi, and its 24-hour cycle is a key, distinguishing fact. No contradictions or underspecification exist. Medical accuracy is sound. Minimal fix: None needed for validity; the item is logically and medically sound as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]